MedPath

Impact of CD177 on extent of and recovery from disability after ischemic stroke

Recruiting
Conditions
I63
Cerebral infarction
Registration Number
DRKS00030825
Lead Sponsor
niversitätsklinikum Essen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
800
Inclusion Criteria

adult patients with first-ever acute (up to 48 hours after symptom onset) ischemic stroke

Exclusion Criteria

previous strokes, subacute or chronic strokes (>48 hours after symptom onset), hemorrhagic strokes, no consent

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IHSS, Barthel-Index, mRS in the acute phase (24-36 hours after hospital admission), subacute phase (72-96 hours) and chronic phase (3 months) stratified by CD177 status
Secondary Outcome Measures
NameTimeMethod
Cognition (MoCA), depressive symptoms (PSD questionnaire by Nolte 2006), quality of life (SF12) stratified by CD177 status
© Copyright 2025. All Rights Reserved by MedPath